Lantern Pharma Inc. (LTRN): Shares Outstanding

Annual figures by period end, from SEC filings.

11.25M
As of 2025-12-31
12.76M
As of 2026-06-30
+1.2%
3-year compound annual growth
+12.6%
5-year compound annual growth
2019-12-31: 1.98M2020-12-31: 6.22M2021-12-31: 11.09M2022-12-31: 10.86M2023-12-31: 10.72M2024-12-31: 10.78M2025-12-31: 11.25M11.25M
2019-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3111.25M+4.4%2026-03-30, Balance as of period end
2024-12-3110.78M+0.6%2026-03-30, Balance as of period end
2023-12-3110.72M-1.3%2025-03-27, Balance as of period end
2022-12-3110.86M-2.1%2024-03-18, Balance as of period end
2021-12-3111.09M+78.3%2023-03-20, Balance as of period end
2020-12-316.22Mn/c2022-03-10, Balance as of period end
2019-12-311.98Mn/a2021-03-10, Balance as of period end